SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MTXX a growth company

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike M who wrote (8)10/22/2003 4:23:01 PM
From: DanZ  Read Replies (2) of 13
 
Wow!

Matrixx's third quarter earnings exceeded even my expectations. I was thinking that 20 cents per share in the third quarter would be good. They earned 29 cents per share. Full story at biz.yahoo.com

Matrixx Initiatives, Inc. Announces 163% Third Quarter 2003 Net Sales Increase; Q3 Net Income Increases 170%
Wednesday October 22, 4:16 pm ET

PHOENIX, Oct. 22 /PRNewswire-FirstCall/ -- Matrixx Initiatives, Inc. (Nasdaq: MTXX - News), developer and distributor of the expanded line of Zicam® products, today announced net sales of $13.4 million for the third quarter of 2003, a 163 percent increase versus $5.1 million in the comparable quarter of 2002. Net income for the quarter was $2.8 million or $0.29 per share, versus $1.0 million, or $0.11 per share for the third quarter of 2002.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext